World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
76
Citations
20550
World Ranking
5050
National Ranking
113

Elda Tagliabue publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Elda Tagliabue sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 369 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Elda Tagliabue D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Elda Tagliabue sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 76 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Elda Tagliabue is affiliated with the Fondazione IRCCS Istituto Nazionale dei Tumori in Italy. Their research primarily spans the fields of biochemistry, genetics, molecular biology, and medicine, with a pronounced focus on oncology, molecular biology, cancer research, immunology, and infectious diseases.

The scientist's work covers various main topics, including:

  • Gut microbiota and health
  • HER2/EGFR in cancer research
  • Cancer cells and metastasis
  • Cancer immunotherapy and biomarkers
  • Cancer, lipids, and metabolism
  • Immune cells in cancer
  • MicroRNA in disease regulation

Some of the recent publications by Elda Tagliabue provide insight into the thematic focus and scientific contributions, featuring:

  • "The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy" (2020), published in Cellular and Molecular Life Sciences
  • "Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer" (2021), published in Cancer Research
  • "Cancer-Associated Adipocytes in Breast Cancer: Causes and Consequences" (2021), published in International Journal of Molecular Sciences
  • "Adipocytes in Breast Cancer, the Thick and the Thin" (2020), published in Cells
  • "Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth" (2021), published in iScience

Frequent coauthors collaborating with Tagliabue include:

  • Tiziana Triulzi
  • Serenella M. Pupa
  • Lucia Sfondrini
  • Francesca Bianchi
  • Loris De Cecco

Publications predominantly appear in journals such as:

  • Cancer Research
  • Cancers
  • International Journal of Molecular Sciences
  • Cells
  • Scientific Reports

Best Publications

  • Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation

    Veronica Huber;Chiara Camisaschi;Angela Berzi;Simona Ferro

  • Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2.

    Roberto Gennari;Sylvie Menard;Francesco Fagnoni;Luisa Ponchio

  • Biologic and therapeutic role of HER2 in cancer.

    Sylvie Ménard;Serenella Marja Pupa;Manuela Campiglio;Elda Tagliabue

  • Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy

    Valentina Ciravolo;Veronica Huber;Gaia C. Ghedini;Elisabetta Venturelli

  • Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificity

    S. Miotti;S. Canevari;S. Ménard;D. Mezzanzanica

  • Replacement of Fhit in cancer cells suppresses tumorigenicity

    Zurab Siprashvili;Gabriella Sozzi;Larry D. Barnes;Peter McCue

  • Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome

    A. Bergamaschi;E. Tagliabue;Therese Sorlie;Therese Sorlie;Bjorn Naume

  • New insights into the role of extracellular matrix during tumor onset and progression.

    Serenella M. Pupa;Sylvie Ménard;Stefania Forti;Elda Tagliabue

  • microRNA-205 Regulates HER3 in Human Breast Cancer

    Marilena V. Iorio;Patrizia Casalini;Claudia Piovan;Gianpiero Di Leva

  • Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis

    Francesco Pezzella;Ugo Pastorino;Elda Tagliabue;Salvatore Andreola

  • Role of HER2 gene overexpression in breast carcinoma.

    Sylvie Ménard;Elda Tagliabue;Manuela Campiglio;Serenella M. Pupa

  • Loss of FHIT Function in Lung Cancer and Preinvasive Bronchial Lesions

    Gabriella Sozzi;Ugo Pastorino;Luisa Moiraghi;Elda Tagliabue

  • Triple-negative breast cancer: Present challenges and new perspectives

    Franca Podo;Lutgarde M.C. Buydens;Hadassa Degani;Riet Hilhorst

  • Immunocytochemical markers in stage I lung cancer: relevance to prognosis.

    Ugo Pastorino;Salvatore Andreola;Elda Tagliabue;Francesco Pezzella

  • FOXP3 Expression and Overall Survival in Breast Cancer

    Andrea Merlo;Patrizia Casalini;Maria Luisa Carcangiu;Chiara Malventano

  • Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.

    Sylvie Mènard;Elda Tagliabue;Silvana Canevari;Giuseppe Fossati

  • Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab

    Alessandra Magnifico;Luisa Albano;Stefano Campaner;Domenico Delia

  • Antitumor Activity of the TLR-5 Ligand Flagellin in Mouse Models of Cancer

    Lucia Sfondrini;Anna Rossini;Dario Besusso;Andrea Merlo

  • Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2

    Stefania Varchetta;Nadia Gibelli;Barbara Oliviero;Elena Nardini

  • The 67 kDa laminin receptor as a prognostic factor in human cancer

    Sylvie Ménard;Elda Tagliabue;Maria Ines Colnaghi

Frequent Co-Authors

Sylvie Ménard
Sylvie Ménard University of Milan
Andrea Balsari
Andrea Balsari University of Milan
Maria I. Colnaghi
Maria I. Colnaghi University of Milan
Gabriella Sozzi
Gabriella Sozzi University of Milan
Carlo M. Croce
Carlo M. Croce The Ohio State University
Claudio Tripodo
Claudio Tripodo FIRC Institute of Molecular Oncology
Ugo Pastorino
Ugo Pastorino University of Milan
Mario P. Colombo
Mario P. Colombo Fondazione IRCCS Istituto Nazionale dei Tumori
Silvana Canevari
Silvana Canevari University of Milan
Silvana Pilotti
Silvana Pilotti University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Biology and Biochemistry opens many pathways, particularly in healthcare, medical coding, and administration. For students interested in healthcare leadership, there are a range of online programs offering flexible options, with healthcare mba cost varying widely depending on the institution and program format.

Another promising route is in medical coding and billing. Gaining a certification can lead to several career tracks with varying salary potential. Understanding the differences in roles is important—compare ccs vs cpc salary to see how credentials might impact your earnings and career outlook.

Medical coding is a strong option for graduates seeking remote or flexible work. Entry-level positions offer competitive pay, as detailed in this guide on medical coding salary. If you’re curious whether this is the right fit, consider the benefits and challenges shared in "is medical coding a good job", which outlines both the rewards and the demands of this growing field.

Best Scientists Citing Elda Tagliabue

Trending Scientists

Recently Published Articles